Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
How much is the Small Animal Imaging (In-Vivo) Market valued at in 2026, and what valuation is forecast for 2030?
The small animal imaging (in-vivo) market has seen substantial expansion in recent years. This market is expected to increase from $3.15 billion in 2025 to $3.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.4%. The historic period’s growth drivers include an uptick in preclinical research activities, increasing investments in drug discovery, expanded academic research funding, the rising utilization of animal models in disease studies, and the availability of advanced imaging modalities.
The small animal imaging (in-vivo) market size is anticipated to experience substantial growth in the coming years. It is projected to reach $5.53 billion by 2030, with a compound annual growth rate (CAGR) of 11.8%. This growth during the forecast period can be linked to factors such as an escalating demand for precision medicine research tools, increasing investments in translational research, the expansion of oncology and neurological studies, a rising adoption of AI-assisted diagnostics, and a greater emphasis on real-time biological imaging. Prominent trends throughout this period include the increased uptake of multimodal imaging systems, a growing application of non-invasive in vivo imaging techniques, the deepening integration of AI-based image analysis, the broadening of longitudinal disease monitoring studies, and an amplified focus on high-resolution imaging capabilities.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp
What Drivers Are Influencing The Growth Of The Small Animal Imaging (In-Vivo) Market?
Increased expenditure in the healthcare sector is anticipated to propel the future growth of the small animal imaging (in vivo) market. This healthcare expenditure encompasses the total public and private costs of health care as a percentage of GDP. A rise in healthcare spending coupled with growing health awareness promotes self-care management, where PET equipment is utilized in methods like small animal imaging. Small animal imaging (in vivo) benefits the healthcare sector by enabling the noninvasive, real-time visualization of biological processes, thereby accelerating drug development, deepening disease understanding, and facilitating the creation of more effective therapies. As an illustration, a report released in May 2024 by the Office for National Statistics, a UK-based governmental statistical body, stated that healthcare spending in the UK rose by 5.6% in nominal terms in 2023, with long-term health and social care expenditure showing a 2.8% increase in real terms in 2022. Hence, the increasing financial outlay for the healthcare sector is driving the expansion of the small animal imaging (in vivo) market.
How Is The Small Animal Imaging (In-Vivo) Market Organized Into Various Segments?
The small animal imaging (in-vivo) market covered in this report is segmented –
1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers
Subsegments:
1) By Micro-MRI: High-Field Micro-MRI Systems, Low-Field Micro-MRI Systems, MRI Contrast Agents
2) By Optical Imaging: In Vivo Fluorescence Imaging Systems, Bioluminescence Imaging Systems, Optical Coherence Tomography Systems
3) By Nuclear Imaging: Positron Emission Tomography (PET) Scanners, Single Photon Emission Computed Tomography (SPECT) Systems, Radioactive Tracers
4) By Other Components: X-Ray Imaging Systems, CT Imaging Systems, Ultrasound Imaging Systems
Which Innovation Trends Are Advancing Developments Within The Small Animal Imaging (In-Vivo) Market?
Major companies operating in the small animal imaging (In-Vivo) market are increasingly prioritizing advanced in vivo imaging software platforms, such as those with real-time kinetic analysis modules. This focus aims to meet the growing need for more accurate, quantitative, and high-throughput preclinical studies in fields like oncology and neuroscience. These software solutions enable continuous capture and automated analysis of dynamic bioluminescent (BLI) signals over time, a departure from traditional static single-timepoint snapshots. This methodology yields richer kinetic curves, improves reproducibility, and facilitates better identification of peak signal phases. For example, in April 2024, Spectral Instruments Imaging, a US-based preclinical imaging technology company, launched Aura 4.5, the most recent version of its in vivo imaging software. Aura 4.5 introduces a Kinetics mode, which permits automated, real-time acquisition of bioluminescent signals across their entire time course, including rise, plateau, and decay phases. The software subsequently identifies and reports the peak bioluminescent intensity, aiding researchers in maximizing sensitivity and biological accuracy. It also streamlines data acquisition processes and reduces the need for manual intervention, thus enhancing workflow efficiency for longitudinal studies. This updated, feature-rich software is especially valuable for longitudinal, time-sensitive research such as pharmacokinetics, gene expression, or infection models.
Who Are The Major Companies Operating In The Small Animal Imaging (In-Vivo) Market?
Major companies operating in the small animal imaging (in-vivo) market are Bruker Corporation, PerkinElmer Inc., Mediso Ltd., Aspect Imaging Ltd., Spectral Instruments Imaging LLC, Bioscan Inc., Gamma Medica-Ideas Inc., LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc., MR Solutions Ltd., MILabs B.V., Trifoil Imaging Inc., VisualSonics Inc., Fujifilm VisualSonics Inc., Sedecal S.A., Kubtec Medical Imaging, Carestream Health Inc., Thermo Fisher Scientific Inc., Rigaku Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report
Which Regions Are Poised For Strategic Growth In The Small Animal Imaging (In-Vivo) Market?
North America was the largest region in the small animal imaging (in-vivo) market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the small animal imaging (in-vivo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Small Animal Imaging (In-Vivo) Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7303&type=smp
Browse Through More Reports Similar to the Global Small Animal Imaging (In-Vivo) Market 2026, By The Business Research Company
Veterinary Imaging Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report
Veterinary Imaging Equipment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-imaging-equipment-global-market-report
Preclinical Imaging Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company